Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Buserelin as primary therapy in advanced prostatic carcinoma.
Presant CA, Soloway MS, Klioze SS, Kosola JW, Yakabow AL, Mendez RG, Kennedy PS, Wyres MR, Naessig VL, Ford KS, et al. Presant CA, et al. Cancer. 1985 Nov 15;56(10):2416-9. doi: 10.1002/1097-0142(19851115)56:10<2416::aid-cncr2820561013>;2-#. Cancer. 1985. PMID: 3930064
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy.
Balch CM, Smalley RV, Bartolucci AA, Burns D, Presant CA, Durant JR. Balch CM, et al. Among authors: presant ca. Cancer. 1982 Mar 15;49(6):1079-84. doi: 10.1002/1097-0142(19820315)49:6<1079::aid-cncr2820490604>;2-x. Cancer. 1982. PMID: 7037155 Clinical Trial.
132 results